Phase 4Not yet recruiting

Combating Related Epidemics in HCV (CREST)

Combating Related Epidemics in HCV Through Simplified Testing and Treatment. A Cluster Randomized Trial of Point-of-care Hepatitis C Testing and Treatment Among Key Populations

Sponsor
Duke University (Academic or other)
Enrollment
1,280 planned
Conditions
HIV - Human Immunodeficiency Virus; Hepatitis B Virus (HBV); HEPATITIS C (HCV)
Interventions
Cepheid GeneXpert HCV Test; INSTI HIV - 1/2 Antibody; bioLytical Laboratories iStatis Hepatitis B Surface Antigen Test; Sofosbuvir / Velpatasvir Oral Tablet [Epclusa]; Sofosbuvir/Velpatasvir/Voxilaprevir
Ages
children, adults, older adults
Registry
NCT07560046

Full record on ClinicalTrials.gov

From the registry

This is a two-arm cluster randomized control trial to evaluate the effectiveness of a single-visit point-of-care (POC) test and treat bundle (intervention arm) compared to the current standard-of-care (SOC, control arm). 1:1 randomization occurs at the site level.

Primary outcomes

  • Proportion of participants who complete the Hepatitis C Virus (HCV) care cascade within 24 weeks of study entry in intervention versus Standard of Care (SOC) arm.

History

  1. Study completion expected

  2. Primary completion expected

  3. Expected to start

  4. Last registry update

  5. Registered